Company / Working Capital
Ventyx Biosciences, Inc. Working Capital History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$216.8M
FY2024
5-year range
-$1.2M / $314.3M
FY2020-FY2024
Trend
-10.4%
vs FY2023
Sector context
#158 of 214
Health Care
What the data says
At $217M, Ventyx Biosciences, Inc.'s working capital ranks #158 of 214 in the Health Care sector. Declined from $314M to $217M over the past 2 years.
Based on SEC 10-K filings.
$217M in FY2024 with a 3-year CAGR of -4.7%.
Declined from $314M to $217M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -4.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#158 of 214 in Health CareTop 74% of 214This company $216.8M Sector average $955.5M
▼
-77.3% below sector average
Key checks
Key Insights
- 3-year CAGR of -4.7%, indicating a declining trend.
- In FY2024, working capital decreased 10.4% year-over-year.
- Ranks #158 out of 214 companies in the Health Care sector.
- Peak working capital was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $216.8M | -10.4% |
| FY2023 | $242.1M | -23.0% |
| FY2022 | $314.3M | +25.4% |
| FY2021 | $250.7M | +21752.6% |
| FY2020 | -$1.2M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026